Impact of family history on choosing risk-reducing surgery among BRCA mutation carriers

被引:53
|
作者
Singh, Krishna [1 ]
Lester, Jenny [2 ]
Karlan, Beth [2 ]
Bresee, Catherine [2 ]
Geva, Tali [1 ]
Gordon, Ora [1 ]
机构
[1] Cedars Sinai Med Ctr, Cedars Sinai Med Genet Inst, Los Angeles, CA 90048 USA
[2] Cedars Sinai Med Ctr, Samuel Oschin Comprehens Canc Inst, Womens Canc Program, Los Angeles, CA 90048 USA
关键词
BRCA mutations; family history; prophylactic mastectomy; prophylactic salpingo-oophorectomy; SALPINGO-OOPHORECTOMY; OVARIAN-CANCER; BREAST; WOMEN; TIME;
D O I
10.1016/j.ajog.2013.01.026
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
OBJECTIVE: Despite substantial survival benefits of risk-reducing mastectomy (RRM) and risk-reducing bilateral salpingo-oophorectomy (RRBSO) among BRCA mutation carriers, only a minority elect to undergo these procedures. This study investigates factors that might influence decision making regarding prophylactic surgeries among women with BRCA mutations. STUDY DESIGN: Unaffected BRCA mutation carriers who were counseled at our center and either underwent prophylactic surgery or participated in a high-risk surveillance program at our institution from 1998 through 2010 were included in the study. Medical records were reviewed and data collected included age, family history, parity, mutation type, history of breast biopsy or cosmetic surgery, and uptake of prophylactic surgeries. RESULTS: Among 136 unaffected women with BRCA mutations, uptake of RRM was 42% and uptake of RRBSO was 52%. Family history of first- and second-degree relatives being deceased from breast cancer was predictive of uptake of RRM and of RRBSO (odds ratio [OR], 11.0; P = .005; and OR, 15.8; P = .023, respectively), and history of a mother lost to pelvic cancer was predictive of uptake of RRBSO (OR, 7.9; P = .001). Parity also predicted both RRM and RRBSO uptake (OR, 4.2; P = .001; and OR, 5.4; P = .003, respectively). Age at the time of genetic testing and history of breast biopsy or cosmetic surgery were not predictive of RRM uptake. CONCLUSION: Perceptions of cancer risk are heavily influenced by particular features of an individual's family history and may be motivators in preventive surgery more than actual cancer risk estimations themselves. Awareness of subtle factors beyond the statistical risk for cancers is relevant when counseling at-risk women.
引用
收藏
页码:329.e1 / 329.e6
页数:6
相关论文
共 50 条
  • [1] Clinical Characteristics and Choices Regarding Risk-Reducing Surgery in BRCA Mutation Carriers
    Stuckey, Ashley
    Dizon, Don
    Wilbur, Jennifer Scalia
    Kent, Jessica
    Tejada-Berges, Trevor
    Gass, Jennifer
    Legare, Robert
    GYNECOLOGIC AND OBSTETRIC INVESTIGATION, 2010, 69 (04) : 270 - 273
  • [2] Occult and subsequent cancer incidence following risk-reducing surgery in BRCA mutation carriers
    Zakhour, Mae
    Danovitch, Yael
    Lester, Jenny
    Rimel, B. J.
    Walsh, Christine S.
    Li, Andrew J.
    Karlan, Beth Y.
    Cass, Ilana
    GYNECOLOGIC ONCOLOGY, 2016, 143 (02) : 231 - 235
  • [3] Acceptability of prophylactic salpingectomy with delayed oophorectomy as risk-reducing surgery among BRCA mutation carriers
    Holman, Laura L.
    Friedman, Sue
    Daniels, Molly S.
    Sun, Charlotte C.
    Lu, Karen H.
    GYNECOLOGIC ONCOLOGY, 2014, 133 (02) : 283 - 286
  • [4] Rates of risk-reducing surgery in Israeli BRCA1 and BRCA2 mutation carriers
    Laitman, Y.
    Vaisman, Y.
    Feldman, D.
    Helpman, L.
    Gitly, M.
    Shimon, S. Paluch
    Berger, R.
    Cohen, L.
    Narod, S. A.
    Friedman, E.
    CLINICAL GENETICS, 2014, 85 (01) : 68 - 71
  • [5] Risk-Reducing Breast and Gynecological Surgery for BRCA Mutation Carriers: A Narrative Review
    Bertozzi, Serena
    Londero, Ambrogio P.
    Xholli, Anjeza
    Azioni, Guglielmo
    Di Vora, Roberta
    Paudice, Michele
    Bucimazza, Ines
    Cedolini, Carla
    Cagnacci, Angelo
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (04)
  • [6] Risk-reducing surgery increases survival in BRCA1/2 mutation carriers unaffected at time of family referral
    Ingham, Sarah L.
    Sperrin, Matthew
    Baildam, Andrew
    Ross, Gary L.
    Clayton, Richard
    Lalloo, Fiona
    Buchan, Iain
    Howell, Anthony
    Evans, D. Gareth R.
    BREAST CANCER RESEARCH AND TREATMENT, 2013, 142 (03) : 611 - 618
  • [7] Risk-Reducing Mastectomy for BRCA Gene Mutation Carriers
    Euhus, David M.
    ANNALS OF SURGICAL ONCOLOGY, 2015, 22 (09) : 2807 - 2809
  • [8] Risk-reducing surgery in BRCA1/BRCA2 mutation carriers: Are there factors associated with the choice?
    Manoukian, Siranoush
    Alfieri, Sara
    Bianchi, Elisabetta
    Peissel, Bernard
    Azzollini, Jacopo
    Borreani, Claudia
    PSYCHO-ONCOLOGY, 2019, 28 (09) : 1871 - 1878
  • [9] Association of Risk-Reducing Surgery in BRCA1 or BRCA2 Mutation Carriers With Cancer Risk and Mortality
    Domchek, Susan M.
    Friebel, Tara M.
    Singer, Christian F.
    Evans, D. Gareth
    Lynch, Henry T.
    Isaacs, Claudine
    Garber, Judy E.
    Neuhausen, Susan L.
    Matloff, Ellen
    Eeles, Rosalind
    Pichert, Gabriella
    Van T'veer, Laura
    Tung, Nadine
    Weitzel, Jeffrey N.
    Couch, Fergus J.
    Rubinstein, Wendy S.
    Ganz, Patricia A.
    Daly, Mary B.
    Olopade, Olufunmilayo I.
    Tomlinson, Gail
    Schildkraut, Joellen
    Blum, Joanne L.
    Rebbeck, Timothy R.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2010, 304 (09): : 967 - 975
  • [10] Adequacy of risk-reducing gynaecologic surgery in BRCA1 or BRCA2 mutation carriers and other women at high risk of pelvic serous cancer
    Kiely, B. E.
    Friedlander, M. L.
    Milne, R. L.
    Stanhope, L.
    Russell, P.
    Jenkins, M. A.
    Weideman, P.
    McLachlan, S. A.
    Grant, P.
    Hopper, J. L.
    Phillips, K. A.
    FAMILIAL CANCER, 2011, 10 (03) : 505 - 514